TEAP Update Presentation for MOP-20 - PowerPoint PPT Presentation

andrew
slide1 l.
Skip this Video
Loading SlideShow in 5 Seconds..
TEAP Update Presentation for MOP-20 PowerPoint Presentation
Download Presentation
TEAP Update Presentation for MOP-20

play fullscreen
1 / 29
Download Presentation
TEAP Update Presentation for MOP-20
297 Views
Download Presentation

TEAP Update Presentation for MOP-20

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. TEAP Update Presentation for MOP-20 T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  2. TEAP/MTOCAssessment of Revised Essential Use Nominations for MDIs and Progress Report T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  3. European Community Russian Federation United States 2009 Recommend exemption for CFCs for MDIs for 22 tonnes. Recommend exemption for CFCs for MDIs for 248 tonnes (for single-moiety salbutamol to be sold within the Russian Federation). - 2010 - - Recommend exemption for CFCs for MDIs for 92 tonnes. Essential Use Nominations for MDIs T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  4. European Community Revised Essential Use Nomination for MDIs • Reduction in CFCs nominated for 2009 (22 tonnes) • 60% intended for Italy; 40% for Article 5 Parties • Three active ingredients withdrawn • New information submitted after OEWG-28 to support the nomination • Demonstrated inaccessibility of available stockpile • Additional information to support volume and essentiality of the combination products to Italy, and on progress in reformulation T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  5. European Community Revised Essential Use Nomination for MDIs • Most MTOC members do not consider these combination products an essential use • However, given that 2009 is the final year of nomination, MTOC reluctantly recommends the nomination owing to: • reformulation progress • inaccessibility of available stockpile T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  6. United States Revised Essential Use Nomination for MDIs • Significant reduction in CFCs nominated for 2010 (92 tonnes) • Two active ingredients withdrawn • New information submitted after OEWG-28 to support the nomination • Claimed inaccessibility of available stockpile with required CFC mix • Additional information to support volume and essentiality of epinephrine CFC MDI to United States, and on progress in reformulation • Active moiety subject to US FDA rule-making, yet to be completed T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  7. United States Revised Essential Use Nomination for MDIs • Some MTOC members did not consider epinephrine CFC MDIs an essential use • MTOC members urge completion of development efforts by beginning of 2011, as planned by manufacturer • MTOC reluctantly recommends the nomination owing to • anticipated reformulation progress, and • inaccessibility of available stockpile • MTOC will not recommend CFC for epinephrine after 2010 T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  8. Phase-out of CFC MDIs in A5 Parties • Significant progress in transition from CFC MDI use in all A5 Parties, with a range of technically feasible alternatives available • Mandated global CFC production phase-out 14 months away • Many MLF projects to convert locally owned CFC MDI manufacturing are still in the early stages • Pace of MLF-financed manufacturing conversion will determine the quantities of CFCs required after 2009 • Continued production of small amounts of pharmaceutical-grade CFCs after 2009 is likely to be impractical T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  9. Update Decision XVIII/16: Recommended Option • A final CFC manufacturing campaign would provide: • A clear target for ending CFC production • Predictability for CFC producers • Incentives for companies to switch manufacturing to CFC-free alternatives • The date for a final campaign production can be set when: • Timelines for project implementation are clear • Projections of CFC requirements are known • Final production campaign of pharma-grade CFCs feasible in 2011 • Requires planning and coordination • Assumes conversion project implementation is not delayed further T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  10. TEAP / CTOC Essential Use Nomination of CFC-113 by the Russian Federation T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  11. Background • Decision XVIII/8 (MOP-18) approved 150 tonnes for 2007 as exemption for CFC-113 applications in the aerospace industry in the Russian Federation • Decision XIX/14 authorized 140 tonnes for 2008 and 130 tonnes for 2009 provided that TEAP identifies no alternatives and noted that: • Experts nominated by TEAP/CTOC will meet with Russian engineers to evaluate the applications and to recommend proven alternatives if possible • The Russian Federation is ready to explore the availability of CFC-113 from global stocks T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  12. Conclusions • The HCFCs (-122 and -141b) have been qualified in the laboratories to replace some uses, but their commercial use still faces significant approval process by various organisations • Successful substitution by 2010 is possible but will require close cooperation between various organisations • The compatibility of the HCFC alternatives with non-metallic materials remains an important issue • Total CFC-113 phase-out will require significant research, testing and initiatives by the Russian space industry T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  13. Recommendations • TEAP and its CTOC reaffirm 140 tonnes of CFC-113 for 2008 and 130 tonnes for 2009 based on progress made to date and work remaining to commercialise HCFC alternatives • Quantities of CFC-113 are likely less necessary in future years provided the Russian Federation successfully implements: • Replacement to HCFCs • Flammable HC/alcohol blends in appropriately designed explosion-rated equipment • Replacement of materials not compatible with HCFC solvents T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  14. TEAP/HTOC Decision XIX/16: Study on Regional Imbalances in the Availability of Halons T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  15. Decision XIX/16 - Update • The TEAP report is not ready for presentation at MOP-20 owing to the limited availability of country data and the late start of the MLF Banking Study • The MLF Banking Study commenced October 2008 and a peer review draft is anticipated by end 2008 • Additional country data has been received since OEWG-28, and HTOC members have been obtaining additional data from their own regional contacts • HTOC will meet in March 2009 to finalise the report for TEAP review and for presentation to the OEWG-29 T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  16. TEAP / RTOC Decision XIX/8 Application of HCFC Alternatives at High Ambient Temperatures T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  17. Decision XIX/8 At MOP-19 in Montreal, Decision XIX/8 was taken related to HCFC alternatives and specific climatic conditions: • To request the TEAP to conduct a scoping study addressing the prospects for the promotion and acceptance of alternatives to HCFCs in the refrigeration and air conditioning sectors in Article 5 Parties, with specific reference to specific climatic conditions and unique operating conditions, such as those in mines that are not open pit mines, in some Article 5 Parties; • To request the TEAP to provide a summary of the outcome of the study referred to in the preceding paragraph in its 2008 progress report with a view to identifying areas requiring more detailed study of the alternatives available and their applicability. T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  18. Status of scoping study • Decision XIX/8 asks for guidance on the replacements for HCFC-22, which is a commonly used refrigerant under hot ambient conditions • The RTOC co-chairs assembled an RTOC sub-committee (6 experts including 2 from an Article 5 Party) • Delay in 2008 occurred due to • difficulties encountered in gathering accurate commercial product data from different countries • logistic difficulties related to the restructuring of the RTOC committee for the 2010 Assessment Report • logistic difficulties in planning travels to South Africa T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  19. Analyses for the scoping study (1) Analyses are being performed regarding the impacts of elevated temperatures when applying candidate HCFC alternative refrigerants (both commercialised and newly proposed ones) on: • capacity and efficiency in representative equipment (mostly via cycle refrigeration models) • capacity and efficiency data from commercially available equipment T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  20. Analyses for the scoping study (2) Difficulties have been and are encountered where it concerns: • data gathering from applicable Article 5 Parties on the present practices and the problems encountered • consistent analyses for unconventional refrigerant candidates • lack of reliable data for specialised equipment and the servicing of this equipment • Logistics, time scale and funding issues are prohibitive for the convening of TEAP/RTOC special-purpose meeting(s) T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  21. Timeline for completion • The scoping study will be open for technical review after January 2009 • The scoping study will be part of the April/May TEAP 2009 Progress Report T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  22. Update of the TEAP - 2008 Task Force on CTC Emissions T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  23. CTC emissions calculated from atmospheric abundances and reported production T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  24. Unexplained CTC emissions • Recent atmospheric measurements of CTC concentrations have remained high despite phase-out • To reconcile bottom-up and estimates from atmospheric concentrations the Task Force developed a model • The model reconciles bottom-up and emission estimates for 1999, but cannot explain recent values • Therefore TEAP and its CTOC conclude that there must be substantial unreported emissions • CTOC will investigate what sources these might be T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  25. Model for CTC emissions The model considers emissions arising from: • Total production • Feedstock uses • Controlled consumption • Emissive uses • Process agents • Imports • Destruction The model is based on: • 1999-2006 figures reported to the Ozone Secretariat • Different emission factors for each step depending on whether A5 or non-A5 Parties T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  26. Emissions from Bottom-Up and Atmospheric Models T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  27. Conclusions • The rapid decrease in model-estimated bottom-up emissions is significantly lower than emissions derived from atmospheric measurements for the range of scientifically determined atmospheric lifetimes • The decrease in emissions from controlled uses seems to being compensated by a rapidly growing new source • More work needs to be done, i.e., explore high growth products such as HCFC-22, which may require co-production of CTC with chloroform T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  28. TEAP Administrative issues T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a

  29. TEAP/ TOC Organisation issues • TEAP requests US $100 k budget for 2009 • For travel and meeting expenses; never for consulting fees or wages; only if approved by TEAP co-chairs & UNEP secretariat • Without budget, TEAP and TOCs will be unable to complete assignments • Sergey Kopylov proposed as Co-Chair of the Halons TOC • Nominated by the Russian Federation • Recommended by TEAP • Positions available • Experts in nutsedge control, orchard replant, forestry and nursery propagation for the MBTOC • Experts in aviation fire protection for the HTOC • Experts in several refrigeration and AC sub-sectors (including high ambient temperature experts) for the RTOC T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a